Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sensus Healthcare, Inc. - Common Stock (NQ:SRTS)

3.924 +0.074 (+1.92%)
Streaming Delayed Price Updated: 9:30 AM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Sensus Healthcare, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Appoints Larry Biscotti to its Board of Directors
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Reports Third Quarter 2025 Financial Results
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Announces the Passing of Director Bill McCall
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
News headline image
Study Published in Dermatologic Therapy Shows Efficacy of Sensus Healthcare’s SRT Combined with Punch Excision to Treat Keloids
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
News headline image
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Avita, Coty, and Sensus and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
News headline image
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
News headline image
SRTS Investors Have Opportunity to Join Sensus Healthcare, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS
From Pomerantz LLP
Via GlobeNewswire
News headline image
Sensus Healthcare Reports Second Quarter 2025 Financial Results
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare to Report Second Quarter 2025 Financial Results and Hold Business Update Conference Call on August 7
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Receipt of MDSAP Certification for Sensus Healthcare’s Full SRT Product Portfolio to Streamline and Accelerate International Sales Efforts
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists
From Sensus Healthcare, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.